Study to Evaluate the Efficacy and Safety of Belviq XR® in Conjunction With Lifestyle Modification for Weight Loss in Obese Adolescents, Age 12 to 17 Years
Clinical trial NCT03338296 · TERMINATED
Trial details
- NCT number
- NCT03338296
- Sponsor
- Eisai Inc.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-28
- Primary completion
- 2020-04-03
- Enrollment
- 278
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.